BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 27503890)

  • 1. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
    Patel PL; Suram A; Mirani N; Bischof O; Herbig U
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
    de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
    J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
    Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
    Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.
    Casillas MA; Brotherton SL; Andrews LG; Ruppert JM; Tollefsbol TO
    Gene; 2003 Oct; 316():57-65. PubMed ID: 14563552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes.
    Bazarov AV; Hines WC; Mukhopadhyay R; Beliveau A; Melodyev S; Zaslavsky Y; Yaswen P
    Cell Cycle; 2009 Oct; 8(20):3373-8. PubMed ID: 19806010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomeres, telomerase, and myc. An update.
    Cerni C
    Mutat Res; 2000 Jan; 462(1):31-47. PubMed ID: 10648922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
    Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
    Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
    Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
    Cassar L; Nicholls C; Pinto AR; Li H; Liu JP
    FASEB J; 2009 Jun; 23(6):1880-92. PubMed ID: 19193721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
    Guilleret I; Benhattar J
    Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
    Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
    Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-9 silencing regulates hTERT expression via β1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells.
    Ponnala S; Chetty C; Veeravalli KK; Dinh DH; Klopfenstein JD; Rao JS
    Cell Signal; 2011 Dec; 23(12):2065-75. PubMed ID: 21855630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells.
    Miyanaga A; Matsumoto M; Beck JA; Horikawa I; Oike T; Okayama H; Tanaka H; Burkett SS; Robles AI; Khan M; Lissa D; Seike M; Gemma A; Mano H; Harris CC
    BMC Cancer; 2021 Mar; 21(1):310. PubMed ID: 33761896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression.
    Lafferty-Whyte K; Bilsland A; Hoare SF; Burns S; Zaffaroni N; Cairney CJ; Keith WN
    Neoplasia; 2010 May; 12(5):405-14. PubMed ID: 20454512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
    Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
    Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
    Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A
    Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
    Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
    Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.